Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

How the FMA flies under the regulatory radar
Law & Regulation

David Chaplin: How the FMA flies under the regulatory radar

The FMA has little power to hold back the tide of scammers.

Tempering great earnings expectations
Markets

Paul McBeth: Tempering great earnings expectations

There’s a lot happening and to look forward to, but NZ is probably still in recession.

Paul McBeth 03 Dec 2024
Labour: The risk of talking to yourself
Opinion

Pattrick Smellie: Labour: The risk of talking to yourself

Labour appears in surprisingly good heart a year after its election defeat.

Pattrick Smellie 02 Dec 2024
A hermit kingdom 'open for business'
Economy

Dileepa Fonseka: A hermit kingdom 'open for business'

NZ needs to come to a new understanding of the balance between values and growth.

Dileepa Fonseka 02 Dec 2024